http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108403764-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-355
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9728
filingDate 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108403764-B
titleOfInvention External preparation for treating recurrent facial dermatitis and preparation method thereof
abstract The invention provides an external preparation for treating recurrent facial dermatitis, which is prepared from the following raw material medicines in parts by weight: 20-40 parts of lucid ganoderma, 10-30 parts of purslane, 10-30 parts of dandelion, 10-30 parts of wild chrysanthemum flower, 5-20 parts of schizonepeta, 5-20 parts of honeysuckle, 5-20 parts of poria cocos and 5-15 parts of mint. Experimental research shows that the external preparation has obvious anti-inflammatory, detumescence and itching relieving effects, stable effect and long action time, and is suitable for people suffering from recurrent facial dermatitis. Meanwhile, the medicine has better compatibility, and has better treatment effect on facial skin allergy and eczema. The invention has novel formula, simple composition, cheap price of each main drug, lower drug cost, simple operation of the preparation method and suitability for industrial production.
priorityDate 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450254702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425172137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453635562

Total number of triples: 45.